latest
statistical data titled Molecular Diagnostics Market has been published by Absolute Markets
Insights to its expansive repository. The report covers penetrative
insights into distinctive market features such as recent trends which are
comprehensively discussed in order to provide an in-depth analysis of the
progress of the industries. Effective research methods such as qualitative and
quantitative analysis are used to obtain accurate data.
Top Key Players includes: Roche
Diagnostics; Abbott; Bio-Rad Laboratories, Inc.; Siemens Healthcare GmbH;
Alere, Inc.; Bayer AG; Dako; Hologic, Inc. (Gen probe); Sysmex Corporation;
Danaher; Johnson & Johnson; Novartis AG; Qiagen N.V.; Becton, Dickinson and
Company; Cepheid; and bioMerieux SA.
Global Molecular Diagnostics
Market was valued at US$ 8750.32 million in 2020 and is expected to reach US$
16359.76 million by 2030, growing at an estimated CAGR of 7.2% over the
forecast period.
Click to view the full report: https://www.absolutemarketsinsights.com/reports/Molecular-Diagnostics-Market-2019-2027-527
The global molecular diagnostics market has been segmented on the
basis of products and services, by application, by technology and by end user.
By Products and Services: During the forecast period,
molecular diagnostic reagents and kits are expected to grow at the fastest rate
in molecular diagnostics market. Molecular Diagnostic Reagents are used to
identify and measure viral and bacterial presences. Molecular reagent testing
provides more accurate treatment of diseases. Manufacturers particularly
concentrate on next-generation technology that will allow biologists to analyse
and interpret the vast amount of genomic data. Technological advancements in
the field of these reagents will include low-cost polymerase chain reaction
equipment and fast identification of amplicons.
By Application: In terms of application, the molecular diagnostics market has
been split into genetic tests, infectious diseases, oncology and others. Over
recent years, the use of molecular diagnostics has increased, and what once was
a technique reserved for specialist centres is now in common use in most
diagnostic labs. Comprehensive molecular diagnostics have now become a standard
of even simple laboratories, treating diseases such as influenza, human
immunodeficiency viruses, methicillin-resistant Staphylococcus aureus,
including the ability to diagnose drug resistance. The key use remains in the
world of virology, where molecular diagnostics have been able to replace long
cultivation methods which allow safe and fast diagnosis.
By Techniques: DNA sequencing is a simple technique for quick results which can
be set up directly in the clinic. Reasons like developments in sequencing
technology and growing focus on the development and launch of diagnostics by
key market players fuel the growth of DNA sequencing. NGS (next-generation
sequencing) kits and panel’s growing awareness and acceptance of personalized
medicine, and expanded use of molecular diagnostic techniques in
pharmacogenetics, genomics science, and point-of-care testing are expected to
fuel the development of this technology in the coming years.
By End User: Private laboratories are dominating in molecular diagnostics
market. These labs receive samples from hospitals or research sites and they
perform diagnostic operations. Many hospitals have integral labs in their
premises and at distance as well. Independent laboratories now a days have
advance sample collection tools, special testing capabilities and provide fast
test results. Thus, growing their influence in Molecular Diagnostic market.
Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-740-024-2424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/
No comments:
Post a Comment